Cartesian Therapeutics, Inc. (RNAC)
(Delayed Data from NSDQ)
$23.32 USD
-3.97 (-14.55%)
Updated Jun 17, 2024 04:00 PM ET
After-Market: $23.34 +0.02 (0.09%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/15/2024
Time: -- |
6/2024 | $-0.81 | 31.82% |
Earnings Summary
For their last quarter, Cartesian Therapeutics, Inc. (RNAC) reported earnings of -$1.97 per share, missing the Zacks Consensus Estimate of -$0.81 per share. This reflects a negative earnings surprise of 143.21%. Look out for RNAC's next earnings release expected on August 15, 2024. For the next earning release, we expect the company to report earnings of -$0.86 per share, reflecting a year-over-year increase of 75.45%.
Earnings History
Price & Consensus
Zacks News for RNAC
What Makes Cartesian Therapeutics, Inc. (RNAC) a New Buy Stock
RNAC: What are Zacks experts saying now?
Zacks Private Portfolio Services